This article is more than 5 years old. Information may no longer be current.
NYU Langone names chief of hematology, medical oncology
Click Here to Manage Email Alerts
Kwok-Kin Wong, MD, PhD, has been named chief of hematology and medical oncology at Perlmutter Cancer Center at NYU Langone Medical Center.
Wong, recognized for his expertise in lung cancer, spent several decades on the faculty at Harvard Medical School and Dana-Farber Cancer Institute. His research has offered insights into the genetic and environmental causes of lung cancer.
“We are tremendously excited to welcome Dr. Wong to NYU Langone,” Benjamin G. Neel, MD, PhD, director of Perlmutter Cancer Center, said in a press release. “His seminal discoveries have identified genes that play important roles in human lung cancer and have shown us how specific cancers will respond to targeted therapies. He will bring a new vision to our hematology-oncology division, bolster our already outstanding lung cancer research program, and help us to recruit more leaders in the field.”
Wong’s most recent investigations have focused on understanding sensitivity and resistance to targeted therapies and immunotherapy, with the hope that insights could lead to curative combination regimens for patients with lung cancer.
“This is an exciting time in cancer research and treatment,” Wong said in the press release. “Advances in genomic technology, targeted therapy and immunotherapy have now directly improved cancer patient survival. It is imperative that we continue to work together to find new combination treatments for each genetically stratified cancer that work even better.”